- Home
- ASMB vs AMPY Comparison
ASMB vs AMPY Comparison
Compare ASMB & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- AMPY
- Stock Information
- Founded
- ASMB 2005
- AMPY 2011
- Country
- ASMB United States
- AMPY United States
- Employees
- ASMB N/A
- AMPY N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- AMPY Oil & Gas Production
- Sector
- ASMB Health Care
- AMPY Energy
- Exchange
- ASMB Nasdaq
- AMPY Nasdaq
- Market Cap
- ASMB 198.6M
- AMPY 164.7M
- IPO Year
- ASMB 2010
- AMPY 2011
- Fundamental
- Price
- ASMB $21.85
- AMPY $3.98
- Analyst Decision
- ASMB Strong Buy
- AMPY Strong Buy
- Analyst Count
- ASMB 4
- AMPY 1
- Target Price
- ASMB $41.33
- AMPY $11.00
- AVG Volume (30 Days)
- ASMB 148.4K
- AMPY 446.9K
- Earning Date
- ASMB 11-06-2025
- AMPY 11-05-2025
- Dividend Yield
- ASMB N/A
- AMPY N/A
- EPS Growth
- ASMB N/A
- AMPY N/A
- EPS
- ASMB N/A
- AMPY 0.38
- Revenue
- ASMB $33,247,000.00
- AMPY $279,289,100.00
- Revenue This Year
- ASMB $12.44
- AMPY $2.33
- Revenue Next Year
- ASMB N/A
- AMPY N/A
- P/E Ratio
- ASMB N/A
- AMPY $10.52
- Revenue Growth
- ASMB 54.77
- AMPY N/A
- 52 Week Low
- ASMB $7.75
- AMPY $2.27
- 52 Week High
- ASMB $27.17
- AMPY $7.35
- Technical
- Relative Strength Index (RSI)
- ASMB 40.57
- AMPY 53.56
- Support Level
- ASMB $22.36
- AMPY $3.72
- Resistance Level
- ASMB $23.61
- AMPY $4.01
- Average True Range (ATR)
- ASMB 1.30
- AMPY 0.17
- MACD
- ASMB -0.60
- AMPY -0.02
- Stochastic Oscillator
- ASMB 3.37
- AMPY 52.00
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.